+91-33-4600-9199  (India), +1-414-240-5010 (U.S.)
Global Digital Therapeutics Market is to witness 22.1% CAGR between 2020-2028- Market Insights, analysis, trends, and forecast - Sheer Analytics and Insights.
Published : Wed Jul 22 2020

According to a new market research report published by sheer analytics and insights, "The Global Digital Therapeutics Market will grow at 22.1% CAGR from 2020 to 2028, as per the latest market research report titled Global Digital Therapeutics Market (By Product Type - Software, and Device. By Application - Diabetes, Obesity, Cardiovascular Disease (CVD), Central Nervous System (CNS) Disease, Respiratory Diseases, Smoking Cessation, Gastrointestinal Disorder (GID), and Others. By End-Use - Patients, Providers, Payers, Employers and Others. By Geography - North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa)– Global industry analysis, size, share, growth, trends, and forecast, 2019-2028, by Sheer Analytics & Insights Pvt. Ltd.

Digital therapeutics is a branch of a digital health system that utilizes online health technology for the treatment of certain medical conditions of the patients. Digital therapeutics helps in the treatment of multiple diseases by making modifications in patient behavior and execute the essential monitoring in order to enhance long-term health results. It can be used to treat numerous diseases such as diabetes, dementia, congestive heart failure, cardiovascular disease, respiratory diseases, and obesity, etc. Digital therapeutics offers a brand-new approach for the treatment of disease in which digital systems empower patients in managing their own health and disease conditions. Digital therapeutics is equipped with the internet, mobile phone, artificial intelligence, machine learning, and big data analytics to optimize treatment for a patient. The Digital Therapeutics Market is majorly driven by factors such as the rising adoption of digital technologies such as smartphones and tablets along with healthcare applications. Moreover, the rising prevalence of chronic diseases and increasing need to curtail escalating healthcare costs are also some of the prominent market driving factors. Further, rising need for preventive healthcare, technological advancements in healthcare, and significant advantages of digital therapeutics such as patient convenience, user-friendliness ability to induce behavioral changes, and enhanced drug compliance is projected to fuel the market demand for Digital Therapeutics over the forecast period. However, lack of awareness about digital therapeutics and patient data privacy concerns can restrain the market growth to some extent.

Geographically, The Digital Therapeutics Market is divided into global regions like Europe, North America, Asia- Pacific, Latin America, Middle East, and Africa.   

The primary key players in the Digital Therapeutics Market include Proteus Digital Health, Omada Health Inc., WellDoc Inc., 2Morrow Inc., Livongo Health, Propeller Health, Twinehealth, Canary Health, Inc., Mango Health, Inc., and Noom Health Inc.

The Global Digital Therapeutics Market Has Been Segmented Into:

Global Digital Therapeutics Market: By Product Type

  • Software
  • Device

Global Digital Therapeutics Market: By Application

  • Diabetes
  • Obesity
  • Cardiovascular Disease (CVD)
  • Central Nervous System (CNS) Disease
  • Respiratory Diseases
  • Smoking Cessation
  • Gastrointestinal Disorder (GID)
  • Others

Global Digital Therapeutics Market: By End Use

  • Patients
  • Providers
  • Payers
  • Employers
  • Others

Global Digital Therapeutics Market: By Region

  • North America
    • USA
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • Japan
    • Australia
    • Rest of Asia Pacific
  • Latin America, Middle East & Africa (LAMEA)
    • Brazil
    • South Africa
    • UAE
    • Rest of LAMEA



About Us     

The global Market Research Industry over a period of time has evolved from being a value proposition driven to become client oriented and output driven.

Sheer Analytics and Insights as a firm has been created to balance the client’s requirements without compromising the core values of Market research in –terms of quality, factual correctness, market awareness, and analysis. Sheer Analytics and Insights goes back to the root of Market Research in terms of TAM (Total Available Market) and PAM (Potential Available Market) and assess the same quantifying all Push and Pull factors.

We in our process provide balance client requirements with value research and create multiple delivery options in terms of products where the client can choose from our varied basket of off the shelf and custom deliverables.

Our products include quick turnaround datasets, TAM/PAM Analysis to full-fledged deep dive research on top trending markets.

Our Key Products

Syndicate Reports: Deep Dive research reports with cross-sectional analysis

Executive Edition: Short Deliverable report focusing on the Top market analysis

Custom Enquiry: Customized Client Reports created in as per client requirements

Passport reports: Database reports

TAM/PAM Analysis: Datasets along with crisp market insights

Sheer Analytics and Insights cover majorly eight industry verticals, including chemicals, life science, communications, electronics, materials, consumer goods, defense, and BFSI sector.


Copyright © 2020 Sheer Analytics and Insights

All Rights Reserved. This document contains highly confidential information and is the sole property of the Company. No part of it may be circulated, copied, quoted, or otherwise reproduced without the approval of the company.

Due to the COVID-19 pandemic, the need for clinically validated digital therapies is unprecedented. This pressing need, combined with the FDA's measures to expand availability of digital therapies for psychiatric disorders, have accelerated launch plans for Orexo's digital offering. This aligns with our strategy to increase our product offering and to further leverage our commercial US infrastructure.
-Nikolaj Sørensen, president and CEO of Orexo AB
Registered Office
RDB Boulevard, 8th Floor, Plot K 1, Sector 5, Block EP and GP, Kolkata 700091, India.
Contact Us
Stay Informed
Submit Your Query
Hot Links